Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism.
Schwann cell proliferation and differentiation that is induced by ferulic acid through MEK1/ERK1/2 signalling promotes peripheral nerve remyelination following crush injury in rats.
Role of Sonic Hedgehog Signaling in Oligodendrocyte Differentiation.
Mercy killing in neurology: The beginnings of neurology on screen (II).
Serological prevalence of celiac disease in Brazilian population of multiple sclerosis, neuromyelitis optica and myelitis.
Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis.
Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy.
Global progress in the control of viral hepatitis and acceptable delay in Hepatitis B immunization.
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Alterations of the human gut microbiome in multiple sclerosis.
High Intensity Aerobic and Resistance Exercise Can Improve Glucose Tolerance in Persons With Multiple Sclerosis: A Randomized Controlled Trial.
Electroconvulsive Therapy in Multiple Sclerosis.
Traumatic brain injury: a risk factor for neurodegenerative diseases.
Cognitive motor interference in multiple sclerosis: Insights from a systematic, quantitative review.
Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis.
Virtual street-crossing performance in persons with multiple sclerosis: Feasibility and task performance characteristics.
Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis.
Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases.
Disease activity in chronic inflammatory demyelinating polyneuropathy.
G Protein-Coupled Receptors in Myelinating Glia.
Glial Cells and Integrity of the Nervous System.
Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
Sex differences and subclinical retinal injury in pediatric-onset MS.
The Effects of Aquatic Exercise on Gait and Strength in Individuals with Multiple Sclerosis: 1426 Board #79 June 2, 8: 00 AM - 9: 30 AM.
Pages
« first
‹ previous
…
826
827
828
829
830
831
832
833
834
…
next ›
last »